Unilife recently announced an agreement with Sanofi to be the sole provider for a minimum of 15 years of cartridge based wearable injectors for all of Sanofi’s large dose volume drugs, excluding insulin. While the details are confidential, it is anticipated that it is for a "fast track" drug for high cholesterol, Alirocumab, which is co- developed by Sanofi and...
As VHC awaits court ruling on damage awards for Apple infringement and licensing deals based on its court validated patents (relating to seamless, secure communication links), the stock is harshly shorted over 35%. I spotted this bullish divergence after a recent bear raid. The stock is very oversold based on RSI. This is a speculative stock not for the faint of heart.
LGF is trading in the bottom of its upward trend range. Will the overall market gloom bring it down? If so, it may be a buying opportunity to scoop up some cheap shares for the run into Mocking Jay 1 blockbuster on 11/21. This stock fundamentally has legs to go to over $40 IMO.
